Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Gastrointest Endosc. 2009 May 24;70(1):96–10924. doi: 10.1016/j.gie.2008.08.040

APPENDIX 3B. White Men.

Efficient screening policies characterized by age range, screening interval and number of scheduled examinations and expressed as the 3% discounted life-time costs and life-expectancy of the policy.

Policy Resources and benefits

No. of scheduled exams Interval between exams (years) Age range Costs ($) Life-expectancy at age 40
1 n.a. 70-70 1,824 21.9125
1 n.a. 65-65 1,831 21.9186
1 n.a. 63-63 1,836 21.9211
1 n.a. 62-62 1,840 21.9221
1 n.a. 61-61 1,848 21.9229
2 14 60-74 1,916 21.9276
2 14 59-73 1,933 21.9288
2 14 58-72 1,953 21.9297
3 9 57-75 2,082 21.9343
3 8 57-73 2,104 21.9350
3 8 56-72 2,141 21.9360
3 9 53-71 2,220 21.9383
4 7 53-74 2,361 21.9412
4 7 52-73 2,413 21.9421
5 6 51-75 2,609 21.9445
6 6 47-77 2,962 21.9478
7 5 48-78 3,103 21.9488
8 5 47-82 3,241 21.9493
8 5 43-78 3,684 21.9511
9 5 43-83 3,723 21.9512
10 5 43-88 3,742 21.9513
10 5 42-87 3,871 21.9513

Lifetime per person cost for CRC screening and treatment after age 40